Cite
Meizlish ML, Goshua G, Liu Y, et al. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis. medRxiv. 2021;doi: 10.1101/2021.01.12.21249577.
Meizlish, M. L., Goshua, G., Liu, Y., Fine, R., Amin, K., Chang, E., DeFilippo, N., Keating, C., Liu, Y., Mankbadi, M., McManus, D., Wang, S., Price, C., Bona, R. D., Chaar, C. I. O., Chun, H. J., Pine, A. B., Rinder, H. M., Siner, J., Neuberg, D. S., Owusu, K. A., & Lee, A. I. (2021). Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.01.12.21249577
Meizlish, Matthew L, et al. "Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.01.12.21249577
Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, DeFilippo N, Keating C, Liu Y, Mankbadi M, McManus D, Wang S, Price C, Bona RD, Chaar CIO, Chun HJ, Pine AB, Rinder HM, Siner J, Neuberg DS, Owusu KA, Lee AI. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis. medRxiv. 2021 Jan 15; doi: 10.1101/2021.01.12.21249577. PMID: 33469595; PMCID: PMC7814841.
Copy
Download .nbib